Alphageneron Pharmaceuticals
Phase 1Alphageneron Pharmaceuticals, Inc., is a privately-held clinical stage biotechnology company, developing targeted natural killer (NK) cell therapies which are supported by Companion Diagnostics. Alphageneron’s team is comprised of industry veterans with experience in both large pharma and biotechnology startups who are committed to transforming the lives of patients with cancer. The Company is based in Boston, Massachusetts with European capabilities in Munich, Germany.
About
Alphageneron Pharmaceuticals, Inc., is a privately-held clinical stage biotechnology company, developing targeted natural killer (NK) cell therapies which are supported by Companion Diagnostics. Alphageneron’s team is comprised of industry veterans with experience in both large pharma and biotechnology startups who are committed to transforming the lives of patients with cancer. The Company is based in Boston, Massachusetts with European capabilities in Munich, Germany.
Funding History
1Total raised: $2M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile